(Q38217720)

English

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1 reference

based on heuristic

inferred from title

object named as

B Wedi

28

0 references

object named as

M Metz

19

0 references

Margarida Gonçalo

object named as

M Gonçalo

11

0 references

Carsten Bindslev-Jensen

object named as

C Bindslev-Jensen

4

0 references

Torsten Zuberbier

1

object named as

T Zuberbier

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Giorgio Walter Canonica

6

object named as

G W Canonica

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

26

object named as

E Toubi

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

31

object named as

M Maurer

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

European Dermatology Forum

34

object named as

European Dermatology Forum

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

5

object named as

Z Brzoza

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

P. Mathelier-Fusade

18

object named as

P Mathelier-Fusade

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Mario Sanchez-Borges

21

object named as

M Sánchez-Borges

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

World Allergy Organization

35

object named as

World Allergy Organization

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

F. Estelle R. Simons

23

object named as

F E R Simons

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

author name string

W Aberer

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

R Asero

3

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

M K Church

7

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

L F Ensina

8

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A Giménez-Arnau

9

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

K Godse

10

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

C Grattan

12

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

J Hebert

13

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

M Hide

14

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A Kaplan

15

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A Kapp

16

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A H Abdul Latiff

17

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

S S Saini

20

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

P Schmid-Grendelmeier

22

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

P Staubach

24

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

G Sussman

25

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

G A Vena

27

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

X J Zhu

29

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A Nast

30

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Dermatology Section of the European Academy of Allergy and Clinical Immunology

32

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Golbal Allergy and Asthma European Network

33

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

publication date

1 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

69

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

e1-29

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Definition, classification, and routine diagnosis of urticaria: a consensus report

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Management of urticaria: a consensus report

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

EAACI/GA2LEN/EDF guideline: management of urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

How to assess disease activity in patients with chronic urticaria?

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Utility of routine laboratory testing in management of chronic urticaria/angioedema

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Development and construct validation of the angioedema quality of life questionnaire

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

German version of ItchyQoL: validation and initial clinical findings

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Ebastine in chronic urticaria: A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

The paradigm of type 1 and type 2 antigen-presenting cells. Implications for atopic allergy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1) -antihistamine dose escalation.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

H1-antihistamine up-dosing in chronic spontaneous urticaria: patients' perspective of effectiveness and side effects--a retrospective survey study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Management of chronic spontaneous urticaria in real life--in accordance with the guidelines? A cross-sectional physician-based survey study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Experience with cyclosporine in children with chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Factors that predict the success of cyclosporine treatment for chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Treatment of chronic autoimmune urticaria with omalizumab

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Successful treatment of solar urticaria with anti-immunoglobulin E therapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Efficacy of omalizumab in delayed pressure urticaria: a case report

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Effective treatment of refractory severe heat urticaria with omalizumab

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Zafirlukast has no beneficial effects in the treatment of chronic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

[Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series].

1 reference

https://api.crossref.org/works/10.1111%2FALL.12370

21 January 2018

Identifiers

10.1111/ALL.12370

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38217720&oldid=2140898111"